compname reports q2 earnings per share $6.05.
sees fy adjusted earnings per share $26 to $28.
q3 adjusted earnings per share $6.82.
qtrly revenue rose 4.3 percent to $4.1 billion.
sees fy sales up 18.5% to 19.5%.
sees 2021 revenue growth in diagnostics by 8% to 10%.
sees fy 2021 base business growth of 21.5% to 22.5%.
qtrly average 114,000 tests per day, compared with 115,000 per day in q2 of 2020.